Wendy Tzou
Concepts (343)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 81 | 2025 | 349 | 16.990 |
Why?
| | Tachycardia, Ventricular | 47 | 2025 | 175 | 12.040 |
Why?
| | Atrial Fibrillation | 26 | 2025 | 390 | 6.930 |
Why?
| | Cardiomyopathies | 18 | 2025 | 350 | 3.770 |
Why?
| | Arrhythmias, Cardiac | 23 | 2024 | 333 | 2.860 |
Why?
| | Electrophysiologic Techniques, Cardiac | 19 | 2024 | 82 | 2.690 |
Why?
| | Cicatrix | 6 | 2022 | 64 | 2.190 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2023 | 130 | 2.100 |
Why?
| | Ventricular Premature Complexes | 9 | 2025 | 36 | 2.010 |
Why?
| | Defibrillators, Implantable | 16 | 2025 | 315 | 1.880 |
Why?
| | Electrocardiography | 21 | 2025 | 630 | 1.770 |
Why?
| | Pacemaker, Artificial | 6 | 2025 | 119 | 1.750 |
Why?
| | Heart Ventricles | 13 | 2025 | 792 | 1.740 |
Why?
| | Heart Diseases | 6 | 2023 | 359 | 1.610 |
Why?
| | Cardiac Electrophysiology | 11 | 2024 | 18 | 1.480 |
Why?
| | Heart Block | 4 | 2024 | 42 | 1.420 |
Why?
| | Pericardium | 9 | 2021 | 56 | 1.400 |
Why?
| | Atrioventricular Block | 2 | 2021 | 37 | 1.320 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 229 | 1.280 |
Why?
| | Amiodarone | 2 | 2021 | 26 | 1.260 |
Why?
| | Cardiac Pacing, Artificial | 5 | 2023 | 87 | 1.220 |
Why?
| | Pulmonary Veins | 3 | 2019 | 99 | 1.210 |
Why?
| | Heart Failure | 7 | 2024 | 2234 | 1.090 |
Why?
| | Death, Sudden, Cardiac | 6 | 2025 | 185 | 1.060 |
Why?
| | Heart Conduction System | 11 | 2024 | 101 | 1.050 |
Why?
| | Atrial Appendage | 3 | 2022 | 17 | 1.010 |
Why?
| | Treatment Outcome | 41 | 2025 | 10800 | 0.960 |
Why?
| | Myocardium | 12 | 2023 | 1002 | 0.950 |
Why?
| | Humans | 125 | 2025 | 137294 | 0.950 |
Why?
| | Echocardiography | 7 | 2025 | 659 | 0.900 |
Why?
| | Electric Countershock | 6 | 2023 | 107 | 0.870 |
Why?
| | Neuromuscular Diseases | 2 | 2024 | 122 | 0.850 |
Why?
| | Anti-Arrhythmia Agents | 9 | 2024 | 114 | 0.850 |
Why?
| | Recurrence | 16 | 2024 | 1059 | 0.840 |
Why?
| | Muscular Dystrophies | 1 | 2023 | 36 | 0.830 |
Why?
| | Electrocardiography, Ambulatory | 3 | 2019 | 63 | 0.810 |
Why?
| | Endocardium | 7 | 2022 | 35 | 0.800 |
Why?
| | Electrodes | 6 | 2022 | 113 | 0.770 |
Why?
| | Myocarditis | 1 | 2023 | 101 | 0.760 |
Why?
| | Pericardial Effusion | 2 | 2022 | 23 | 0.740 |
Why?
| | Heart Atria | 7 | 2025 | 136 | 0.730 |
Why?
| | Carotid Arteries | 4 | 2006 | 209 | 0.720 |
Why?
| | Postoperative Complications | 7 | 2019 | 2658 | 0.670 |
Why?
| | Esophagus | 3 | 2023 | 255 | 0.660 |
Why?
| | Surgery, Computer-Assisted | 1 | 2021 | 98 | 0.650 |
Why?
| | Ablation Techniques | 2 | 2019 | 36 | 0.640 |
Why?
| | Cardiology | 5 | 2020 | 278 | 0.640 |
Why?
| | Consensus | 11 | 2020 | 680 | 0.630 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2022 | 383 | 0.620 |
Why?
| | Tunica Intima | 4 | 2008 | 84 | 0.580 |
Why?
| | Aged | 42 | 2025 | 23851 | 0.570 |
Why?
| | Middle Aged | 51 | 2025 | 33310 | 0.550 |
Why?
| | Risk Factors | 21 | 2025 | 10368 | 0.550 |
Why?
| | Heart Rate | 6 | 2019 | 823 | 0.550 |
Why?
| | Action Potentials | 7 | 2019 | 495 | 0.530 |
Why?
| | Epicardial Mapping | 5 | 2022 | 5 | 0.510 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2017 | 46 | 0.510 |
Why?
| | Tachycardia, Supraventricular | 2 | 2021 | 43 | 0.490 |
Why?
| | Cardiac Catheters | 4 | 2020 | 15 | 0.490 |
Why?
| | Therapeutic Irrigation | 4 | 2020 | 79 | 0.480 |
Why?
| | Bradycardia | 3 | 2025 | 55 | 0.480 |
Why?
| | Atrial Flutter | 3 | 2024 | 36 | 0.480 |
Why?
| | Registries | 9 | 2025 | 2016 | 0.480 |
Why?
| | Male | 61 | 2025 | 67560 | 0.470 |
Why?
| | Venous Thrombosis | 1 | 2017 | 190 | 0.460 |
Why?
| | Syncope, Vasovagal | 2 | 2025 | 6 | 0.460 |
Why?
| | Risk Assessment | 14 | 2024 | 3439 | 0.460 |
Why?
| | Body Temperature | 3 | 2015 | 221 | 0.440 |
Why?
| | Catheters | 4 | 2022 | 72 | 0.440 |
Why?
| | Sarcoidosis | 3 | 2024 | 159 | 0.440 |
Why?
| | Arthritis, Rheumatoid | 1 | 2023 | 1167 | 0.440 |
Why?
| | Female | 59 | 2025 | 73052 | 0.430 |
Why?
| | Multimodal Imaging | 3 | 2019 | 116 | 0.430 |
Why?
| | Bundle-Branch Block | 3 | 2023 | 31 | 0.420 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2013 | 21 | 0.410 |
Why?
| | Societies, Medical | 5 | 2020 | 822 | 0.410 |
Why?
| | Aortic Valve | 4 | 2023 | 352 | 0.410 |
Why?
| | Time Factors | 13 | 2025 | 6818 | 0.390 |
Why?
| | Heart | 6 | 2022 | 657 | 0.370 |
Why?
| | Atrioventricular Node | 2 | 2021 | 15 | 0.370 |
Why?
| | Swine | 7 | 2023 | 774 | 0.360 |
Why?
| | Predictive Value of Tests | 8 | 2019 | 2032 | 0.360 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 2 | 2021 | 30 | 0.350 |
Why?
| | Retrospective Studies | 26 | 2025 | 15639 | 0.340 |
Why?
| | Heart Valve Prosthesis | 2 | 2025 | 116 | 0.340 |
Why?
| | Stroke Volume | 9 | 2025 | 619 | 0.330 |
Why?
| | Cattle | 12 | 2020 | 981 | 0.330 |
Why?
| | Incidence | 7 | 2021 | 2808 | 0.330 |
Why?
| | Anticoagulants | 4 | 2025 | 662 | 0.330 |
Why?
| | Carotid Artery Diseases | 2 | 2008 | 66 | 0.330 |
Why?
| | Tunica Media | 3 | 2008 | 38 | 0.330 |
Why?
| | Ventricular Fibrillation | 2 | 2025 | 60 | 0.320 |
Why?
| | Cardiac Catheterization | 2 | 2022 | 528 | 0.320 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2025 | 389 | 0.310 |
Why?
| | Ventricular Function, Left | 5 | 2021 | 540 | 0.310 |
Why?
| | Ultrasonography | 3 | 2008 | 752 | 0.300 |
Why?
| | Follow-Up Studies | 13 | 2024 | 5125 | 0.280 |
Why?
| | Cardiac Surgical Procedures | 3 | 2021 | 530 | 0.280 |
Why?
| | Survival Rate | 5 | 2019 | 1970 | 0.270 |
Why?
| | Decision Support Techniques | 2 | 2022 | 418 | 0.270 |
Why?
| | Body Surface Potential Mapping | 5 | 2019 | 8 | 0.270 |
Why?
| | Hypercapnia | 1 | 2007 | 53 | 0.270 |
Why?
| | Reoperation | 3 | 2019 | 583 | 0.260 |
Why?
| | Coronary Circulation | 1 | 2007 | 141 | 0.260 |
Why?
| | Genetic Testing | 1 | 2009 | 454 | 0.250 |
Why?
| | Adult | 26 | 2025 | 37724 | 0.250 |
Why?
| | Cardiac Imaging Techniques | 2 | 2019 | 22 | 0.250 |
Why?
| | Thromboembolism | 2 | 2025 | 119 | 0.240 |
Why?
| | Blood Flow Velocity | 1 | 2007 | 412 | 0.240 |
Why?
| | Arteriosclerosis | 1 | 2005 | 88 | 0.240 |
Why?
| | Mitral Valve Prolapse | 1 | 2025 | 9 | 0.240 |
Why?
| | Coronary Vessels | 1 | 2007 | 246 | 0.230 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2024 | 1464 | 0.230 |
Why?
| | Bundle of His | 2 | 2023 | 18 | 0.230 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 163 | 0.230 |
Why?
| | Accessory Atrioventricular Bundle | 2 | 2021 | 13 | 0.220 |
Why?
| | Hot Temperature | 3 | 2023 | 394 | 0.220 |
Why?
| | Amyloidosis | 1 | 2024 | 43 | 0.220 |
Why?
| | Patient Discharge | 2 | 2025 | 906 | 0.220 |
Why?
| | Reproducibility of Results | 6 | 2019 | 3283 | 0.220 |
Why?
| | Cholesterol | 1 | 2005 | 410 | 0.210 |
Why?
| | Rheumatic Diseases | 1 | 2024 | 81 | 0.210 |
Why?
| | Liposomes | 2 | 2023 | 220 | 0.210 |
Why?
| | Animals | 19 | 2023 | 36862 | 0.210 |
Why?
| | Biophysical Phenomena | 2 | 2020 | 64 | 0.200 |
Why?
| | Multicenter Studies as Topic | 2 | 2024 | 308 | 0.200 |
Why?
| | Physicians, Women | 1 | 2024 | 82 | 0.200 |
Why?
| | United States | 13 | 2025 | 14742 | 0.200 |
Why?
| | Carps | 1 | 2022 | 4 | 0.200 |
Why?
| | Encephalitis Virus, Japanese | 1 | 2022 | 2 | 0.190 |
Why?
| | Encephalitis, Japanese | 1 | 2022 | 3 | 0.190 |
Why?
| | Prospective Studies | 7 | 2024 | 7595 | 0.190 |
Why?
| | Temperature | 2 | 2023 | 677 | 0.190 |
Why?
| | Quantum Dots | 1 | 2022 | 36 | 0.190 |
Why?
| | Metabolic Syndrome | 1 | 2005 | 354 | 0.180 |
Why?
| | Philadelphia | 3 | 2019 | 49 | 0.180 |
Why?
| | Pre-Excitation Syndromes | 1 | 2021 | 5 | 0.180 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2021 | 25 | 0.180 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 2 | 2012 | 57 | 0.180 |
Why?
| | Skin | 1 | 2005 | 751 | 0.170 |
Why?
| | Patient Reported Outcome Measures | 1 | 2024 | 406 | 0.170 |
Why?
| | Coronary Sinus | 1 | 2020 | 7 | 0.170 |
Why?
| | Papillary Muscles | 1 | 2019 | 13 | 0.160 |
Why?
| | Prevalence | 5 | 2021 | 2715 | 0.160 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 24 | 0.160 |
Why?
| | Heart-Assist Devices | 2 | 2023 | 552 | 0.160 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 47 | 0.160 |
Why?
| | Patient Safety | 2 | 2020 | 309 | 0.160 |
Why?
| | Length of Stay | 1 | 2025 | 1218 | 0.160 |
Why?
| | Prognosis | 7 | 2019 | 4026 | 0.150 |
Why?
| | Esophageal Fistula | 1 | 2019 | 19 | 0.150 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 69 | 0.150 |
Why?
| | Colorado | 3 | 2019 | 4527 | 0.150 |
Why?
| | In Vitro Techniques | 5 | 2020 | 1089 | 0.150 |
Why?
| | Kaplan-Meier Estimate | 4 | 2018 | 892 | 0.150 |
Why?
| | Heparin | 1 | 2020 | 259 | 0.150 |
Why?
| | Hypertension | 2 | 2017 | 1285 | 0.140 |
Why?
| | Fibrosis | 2 | 2018 | 552 | 0.140 |
Why?
| | Medicare | 3 | 2022 | 758 | 0.140 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 283 | 0.130 |
Why?
| | Materials Testing | 2 | 2016 | 357 | 0.130 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 488 | 0.130 |
Why?
| | Environment | 1 | 2018 | 362 | 0.130 |
Why?
| | Echocardiography, Transesophageal | 1 | 2017 | 101 | 0.130 |
Why?
| | Magnets | 1 | 2016 | 19 | 0.130 |
Why?
| | Disease Management | 1 | 2020 | 627 | 0.120 |
Why?
| | Heart Injuries | 1 | 2016 | 37 | 0.120 |
Why?
| | Ferric Compounds | 1 | 2016 | 56 | 0.120 |
Why?
| | Mitral Valve | 2 | 2019 | 89 | 0.120 |
Why?
| | Equipment Design | 4 | 2020 | 522 | 0.120 |
Why?
| | Thermography | 1 | 2015 | 11 | 0.120 |
Why?
| | Adipose Tissue | 1 | 2020 | 630 | 0.120 |
Why?
| | Metal Nanoparticles | 1 | 2016 | 89 | 0.120 |
Why?
| | Blood Coagulation | 1 | 2017 | 254 | 0.120 |
Why?
| | Odds Ratio | 2 | 2010 | 1067 | 0.120 |
Why?
| | Hypoxia | 1 | 2022 | 1111 | 0.120 |
Why?
| | Adiposity | 1 | 2020 | 518 | 0.120 |
Why?
| | Medical Records | 1 | 2015 | 174 | 0.110 |
Why?
| | Heart Transplantation | 1 | 2020 | 747 | 0.110 |
Why?
| | Nanotubes, Carbon | 1 | 2014 | 48 | 0.110 |
Why?
| | Fee-for-Service Plans | 1 | 2014 | 85 | 0.110 |
Why?
| | Stroke | 1 | 2022 | 1134 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 4 | 2025 | 3568 | 0.110 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 30 | 0.110 |
Why?
| | Energy Transfer | 1 | 2013 | 46 | 0.110 |
Why?
| | Systole | 2 | 2019 | 191 | 0.100 |
Why?
| | Feasibility Studies | 2 | 2015 | 949 | 0.100 |
Why?
| | Primary Prevention | 1 | 2014 | 197 | 0.100 |
Why?
| | Hemodynamics | 1 | 2017 | 1110 | 0.100 |
Why?
| | Sinus of Valsalva | 1 | 2012 | 10 | 0.100 |
Why?
| | Cohort Studies | 5 | 2021 | 5726 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 834 | 0.090 |
Why?
| | Artificial Intelligence | 3 | 2023 | 277 | 0.090 |
Why?
| | Heart Septum | 1 | 2011 | 27 | 0.090 |
Why?
| | Myocardial Ischemia | 1 | 2012 | 263 | 0.090 |
Why?
| | Asia | 2 | 2020 | 70 | 0.080 |
Why?
| | Pressure | 1 | 2011 | 222 | 0.080 |
Why?
| | Latin America | 2 | 2020 | 95 | 0.080 |
Why?
| | Telemetry | 1 | 2010 | 40 | 0.080 |
Why?
| | Pennsylvania | 1 | 2010 | 116 | 0.080 |
Why?
| | Brugada Syndrome | 1 | 2009 | 10 | 0.080 |
Why?
| | Genetic Diseases, Inborn | 1 | 2009 | 42 | 0.080 |
Why?
| | Heart Valve Diseases | 1 | 2011 | 152 | 0.080 |
Why?
| | Logistic Models | 2 | 2014 | 2071 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2679 | 0.070 |
Why?
| | Nanoparticles | 1 | 2014 | 484 | 0.070 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2011 | 182 | 0.070 |
Why?
| | Reference Values | 2 | 2010 | 818 | 0.070 |
Why?
| | Pharmacogenetics | 1 | 2009 | 179 | 0.070 |
Why?
| | Office Visits | 1 | 2008 | 91 | 0.070 |
Why?
| | Age Factors | 2 | 2018 | 3297 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 1946 | 0.070 |
Why?
| | Severity of Illness Index | 3 | 2018 | 2836 | 0.070 |
Why?
| | Blood Gas Analysis | 1 | 2007 | 74 | 0.070 |
Why?
| | Comorbidity | 2 | 2017 | 1624 | 0.070 |
Why?
| | Coronary Artery Disease | 1 | 2013 | 703 | 0.070 |
Why?
| | Miniaturization | 1 | 2006 | 22 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1260 | 0.060 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2021 | 143 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2018 | 2419 | 0.060 |
Why?
| | Professional Competence | 1 | 2006 | 100 | 0.060 |
Why?
| | Waist-Hip Ratio | 1 | 2005 | 39 | 0.060 |
Why?
| | Pattern Recognition, Automated | 1 | 2006 | 73 | 0.060 |
Why?
| | Myocardial Contraction | 1 | 2007 | 340 | 0.060 |
Why?
| | Pilot Projects | 2 | 2021 | 1700 | 0.060 |
Why?
| | Aged, 80 and over | 4 | 2018 | 7607 | 0.060 |
Why?
| | Carotid Stenosis | 1 | 2006 | 91 | 0.060 |
Why?
| | Blood Pressure | 2 | 2017 | 1776 | 0.060 |
Why?
| | Ultrasonography, Doppler | 1 | 2005 | 123 | 0.060 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2024 | 75 | 0.060 |
Why?
| | Confidence Intervals | 1 | 2005 | 330 | 0.060 |
Why?
| | Lipoproteins | 1 | 2005 | 168 | 0.060 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2024 | 6 | 0.060 |
Why?
| | Age Distribution | 1 | 2005 | 391 | 0.060 |
Why?
| | Sex Distribution | 1 | 2005 | 376 | 0.060 |
Why?
| | Cardiologists | 1 | 2024 | 45 | 0.050 |
Why?
| | ROC Curve | 2 | 2018 | 548 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2006 | 267 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2008 | 548 | 0.050 |
Why?
| | Sternotomy | 1 | 2023 | 26 | 0.050 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2016 | 193 | 0.050 |
Why?
| | Triglycerides | 1 | 2005 | 524 | 0.050 |
Why?
| | Protamines | 1 | 2023 | 7 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 812 | 0.050 |
Why?
| | Linear Models | 1 | 2005 | 846 | 0.050 |
Why?
| | Diagnosis, Differential | 2 | 2020 | 1484 | 0.050 |
Why?
| | Survival Analysis | 2 | 2018 | 1321 | 0.050 |
Why?
| | Adolescent | 5 | 2021 | 21499 | 0.050 |
Why?
| | Mentors | 1 | 2024 | 199 | 0.050 |
Why?
| | Career Choice | 1 | 2024 | 216 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1521 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2022 | 112 | 0.050 |
Why?
| | Chlorides | 1 | 2022 | 136 | 0.050 |
Why?
| | Sex Factors | 2 | 2018 | 2073 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2024 | 562 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 533 | 0.050 |
Why?
| | Atherosclerosis | 1 | 2006 | 415 | 0.050 |
Why?
| | Viral Envelope Proteins | 1 | 2022 | 84 | 0.050 |
Why?
| | Tachycardia | 1 | 2021 | 58 | 0.050 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2021 | 30 | 0.040 |
Why?
| | Anesthesia | 1 | 2024 | 192 | 0.040 |
Why?
| | Factor Xa Inhibitors | 1 | 2023 | 171 | 0.040 |
Why?
| | Doxorubicin | 1 | 2023 | 365 | 0.040 |
Why?
| | Vagus Nerve | 1 | 2021 | 86 | 0.040 |
Why?
| | Databases, Factual | 2 | 2018 | 1355 | 0.040 |
Why?
| | Rivaroxaban | 1 | 2023 | 254 | 0.040 |
Why?
| | Psychometrics | 1 | 2024 | 723 | 0.040 |
Why?
| | Carbon | 1 | 2022 | 223 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2021 | 400 | 0.040 |
Why?
| | Warfarin | 1 | 2020 | 151 | 0.040 |
Why?
| | Antithrombins | 1 | 2020 | 60 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 482 | 0.040 |
Why?
| | Tricuspid Valve | 1 | 2019 | 30 | 0.040 |
Why?
| | Operative Time | 1 | 2020 | 146 | 0.040 |
Why?
| | Young Adult | 4 | 2021 | 13163 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2008 | 1302 | 0.040 |
Why?
| | Europe | 1 | 2020 | 414 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 324 | 0.040 |
Why?
| | Patient Participation | 1 | 2022 | 417 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 52 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 199 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 245 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 94 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2752 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 107 | 0.040 |
Why?
| | Hemorrhage | 1 | 2023 | 723 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2005 | 2850 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 98 | 0.030 |
Why?
| | Italy | 1 | 2017 | 109 | 0.030 |
Why?
| | Advisory Committees | 1 | 2019 | 219 | 0.030 |
Why?
| | Oxygen | 1 | 2022 | 935 | 0.030 |
Why?
| | Body Mass Index | 1 | 2005 | 2373 | 0.030 |
Why?
| | Prosthesis Fitting | 1 | 2016 | 17 | 0.030 |
Why?
| | Thermal Conductivity | 1 | 2016 | 5 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 741 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 972 | 0.030 |
Why?
| | Blood Glucose | 1 | 2005 | 2182 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 384 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 898 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 195 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2016 | 4284 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 22 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1774 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 44 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 319 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 586 | 0.030 |
Why?
| | Biomarkers | 1 | 2005 | 4164 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 132 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1459 | 0.030 |
Why?
| | Friction | 1 | 2013 | 14 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1623 | 0.030 |
Why?
| | Health Care Costs | 1 | 2017 | 387 | 0.030 |
Why?
| | Internship and Residency | 1 | 2024 | 1137 | 0.030 |
Why?
| | Czech Republic | 1 | 2013 | 3 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2012 | 3546 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 180 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5436 | 0.030 |
Why?
| | Motion | 1 | 2013 | 98 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 740 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2017 | 903 | 0.030 |
Why?
| | Surface Properties | 1 | 2013 | 416 | 0.020 |
Why?
| | Algorithms | 2 | 2012 | 1692 | 0.020 |
Why?
| | Veins | 1 | 2012 | 62 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 1237 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2885 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 234 | 0.020 |
Why?
| | Quality Improvement | 1 | 2019 | 1172 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 207 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2012 | 312 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3202 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3956 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1318 | 0.020 |
Why?
| | Patient Readmission | 1 | 2014 | 703 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1773 | 0.020 |
Why?
| | Wisconsin | 1 | 2008 | 102 | 0.020 |
Why?
| | Physicians' Offices | 1 | 2006 | 16 | 0.020 |
Why?
| | Observer Variation | 1 | 2006 | 345 | 0.010 |
Why?
| | Image Enhancement | 1 | 2006 | 190 | 0.010 |
Why?
| | Motivation | 1 | 2008 | 568 | 0.010 |
Why?
| | Health Behavior | 1 | 2008 | 757 | 0.010 |
Why?
| | Population Surveillance | 1 | 2006 | 473 | 0.010 |
Why?
| | Family Practice | 1 | 2006 | 462 | 0.010 |
Why?
| | Child | 1 | 2021 | 21999 | 0.010 |
Why?
|
|
Tzou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|